This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Robotics Maker Ekso Aims to Help Wheelchair-Bound to Walk

Stocks in this article: EKSO LMT

Ekso has a little history as well. The original research that launched the Ekso Bionic suit took place at the Berkeley Robotics and Human Engineering Laboratory at the University of California at Berkeley in 2005, with mechanical engineering professor Homayoon Kazerooni and Ekso co-founders Harding and Russ Angold partnering with the lab, as ExoWorks. Angold is now Ekso's chief technology officer.

In 2007, ExoWorks became Berkeley Bionics and began working off a $10 million grant from the Defense Advanced Research Projects Agency. DARPA is an offshoot of the Defense Department, known for its ground-breaking research projects. The grant resulted in the Human Universal Load Carrier (HULC), an exoskeleton suit that helps soldiers to carry heavy loads. In 2009, that technology was licensed to Lockheed Martin (LMT) for further military development. The latest version of the HULC can allow soldiers to carry up to 200 pounds over long distances and rough terrain.

A year later, Berkeley Bionics debuted eLEGS, a predecessor to the Ekso Bionics suit. In 2010, the company changed its name to Ekso Bionics. In 2012, it shipped the first Ekso Bionic suit to Craig Hospital in Englewood, Colo.

Today, there are 22 rehabilitation centers in the U.S. using Ekso suits, eight facilities in Europe and one in South Africa.

The company is focused on the rehabilitation market.

"There are 3,500 rehab centers in the U.S. that deal with spinal and brain injuries that could use the Ekso," Harding said.

The suit is sold at a list price of $110,000 plus another $40,000 for a software upgrade and a $10,000-a-year maintenance agreement. The software upgrade enables a new feature called variable assist, which allows clinicians to target patients' strengths and weaknesses to make rehabilitation more productive.

Ekso has tried to continually upgrade its technology. The company recently rolled out the Ekso GT, a higher performing suit and the fourth evolution in two years.

"We are creating a new industry," CFO Max Scheder-Bieschin said.

The suit is used to train people with neurological conditions such as stroke, traumatic brain injury and hemiparesis (a weakness on one side of the body) to walk again. A patient wears the suit works with a spotter and physical therapy personnel. According to the company, the Ekso can be used by patients with C7 spinal injury (paralysis of the legs and partial body paralysis) and incomplete spinal cord injury, and can also be used by non- or pre-ambulatory patients following a stroke.

2 of 5

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs